218 related articles for article (PubMed ID: 26637198)
1. Prognostic value of pathological response to neoadjuvant chemotherapy in bulky stage Ib2 and IIa cervical squamous cell cancer patients.
Liang Y; Lü B; Chen X; Qin J; Cheng X; Xie X; Lü W
Virchows Arch; 2016 Mar; 468(3):329-36. PubMed ID: 26637198
[TBL] [Abstract][Full Text] [Related]
2. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival following neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer.
Benedetti-Panici P; Greggi S; Scambia G; Amoroso M; Salerno MG; Maneschi F; Cutillo G; Paratore MP; Scorpiglione N; Mancuso S
Eur J Cancer; 1998 Feb; 34(3):341-6. PubMed ID: 9640219
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of neoadjuvant chemotherapy plus radical surgery in patients with bulky stage II cervical squamous cell carcinoma: A retrospective cohort study.
Qin T; Zhen J; Zhou M; Wu H; Ren R; Qu B; Wang H
Int J Surg; 2016 Jun; 30():121-5. PubMed ID: 27131759
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of neoadjuvant paclitaxel-carboplatin chemotherapy followed by radical hysterectomy compared to radical hysterectomy alone in bulky stage IB2-IIA cervical cancer.
Prueksaritanond N; Chaisarn P; Yanaranop M
J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S55-61. PubMed ID: 22619888
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of neoadjuvant chemotherapy with irinotecan hydrochloride and nedaplatin followed by radical hysterectomy for bulky stage Ib2 to IIb, cervical squamous cell carcinoma: Japanese Gynecologic Oncology Group study (JGOG 1065).
Yamaguchi S; Nishimura R; Yaegashi N; Kiguchi K; Sugiyama T; Kita T; Kubushiro K; Kokawa K; Hiura M; Mizutani K; Yamamoto K; Takizawa K
Oncol Rep; 2012 Aug; 28(2):487-93. PubMed ID: 22614251
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
[TBL] [Abstract][Full Text] [Related]
11. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
[TBL] [Abstract][Full Text] [Related]
13. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy with cisplatin and paclitaxel in locally advanced cervical cancer: has this regimen still a role as neoadjuvant setting?
Moioli M; Papadia A; Mammoliti S; Pacella E; Menoni S; Menada MV; Ragni N
Minerva Ginecol; 2012 Apr; 64(2):95-107. PubMed ID: 22481620
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
[TBL] [Abstract][Full Text] [Related]
16. Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: an Italian multicenter retrospective study (CTF Study).
Gadducci A; Sartori E; Maggino T; Zola P; Cosio S; Zizioli V; Lapresa M; Piovano E; Landoni F
Gynecol Oncol; 2013 Dec; 131(3):640-4. PubMed ID: 24096111
[TBL] [Abstract][Full Text] [Related]
17. [Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
Shoji T; Takatori E; Murai M; Hatayama S; Omi H; Kagabu M; Honda T; Kumagai S; Morohara Y; Yoshizaki A; Sugiyama T; Kaido Y; Miura F; Satoh A
Gan To Kagaku Ryoho; 2010 Apr; 37(4):643-8. PubMed ID: 20414019
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR
Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
[TBL] [Abstract][Full Text] [Related]
20. [Histological evaluation of cervical carcinomas in FIGO stage Ib2/IIa after neoadjuvant chemotherapy].
CHEN XD; SHI HY; LÜ WG; QIN JL
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):173-6. PubMed ID: 21575388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]